Search Results for: STK11

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
STK24 serine/threonine kinase 24
  • Apoptotic cleavage of cellular proteins
  • Apoptotic execution phase
  • Fostamatinib
TEAD2 TEA domain transcription factor 2
  • YAP1- and WWTR1 (TAZ)-stimulated gene expression
  • RUNX3 regulates YAP1-mediated transcription
TERT telomerase reverse transcriptase
  • Telomere Extension By Telomerase
  • Formation of the beta-catenin:TCF transactivating complex
  • Zidovudine
  • Grn163l
  • Tertomotide
  • Cri du chat syndrome; Cat cry syndrome; Chromosme 5p deletion syndrome
TNIP2 TNFAIP3 interacting protein 2
  • MAP3K8 (TPL2)-dependent MAPK1/3 activation
  • Ovarian tumor domain proteases
ABCB5 ATP binding cassette subfamily B member 5
  • ABC-family proteins mediated transport
  • Biricodar
  • Dofequidar
ARG2 arginase 2
  • Urea cycle
  • Arginine
  • Ornithine
  • S-2-(Boronoethyl)-L-Cysteine
CDC14B cell division cycle 14B
  • MAPK6/MAPK4 signaling
CRY2 cryptochrome circadian regulator 2
  • Circadian Clock
D2HGDH D-2-hydroxyglutarate dehydrogenase
  • Interconversion of 2-oxoglutarate and 2-hydroxyglutarate
EEF1A2 eukaryotic translation elongation factor 1 alpha 2
  • Eukaryotic Translation Elongation
ETV4 ETS variant transcription factor 4
  • MAPK6/MAPK4 signaling
  • Ewing's sarcoma
  • Prostate cancer
FBP1 fructose-bisphosphatase 1
  • Gluconeogenesis
  • Adenosine phosphate
  • 2,5-Anhydroglucitol-1,6-Biphosphate
  • {4-[3-(6,7-Diethoxy-Quinazolin-4-Ylamino)-Phenyl]-Thiazol-2-Yl}-Methanol
  • Mdl-29951
  • Fructose-6-phosphate
  • MB-07803
  • Managlinat dialanetil
  • N-[7-(3-AMINOPHENYL)-5-METHOXY-1,3-BENZOXAZOL-2-YL]-2,5-DICHLOROBENZENESULFONAMIDE
  • 2,5-DICHLORO-N-(5-CHLORO-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDE
  • 2,5-DICHLORO-N-[5-METHOXY-7-(6-METHOXYPYRIDIN-3-YL)-1,3-BENZOXAZOL-2-YL]BENZENESULFONAMIDE
  • 4-AMINO-N-[(2-SULFANYLETHYL)CARBAMOYL]BENZENESULFONAMIDE
  • Fructose-1,6-bisphosphatase deficiency
FBP2 fructose-bisphosphatase 2
  • Gluconeogenesis
GNPDA1 glucosamine-6-phosphate deaminase 1
  • Glycolysis
  • Beta-D-Glucose
  • 2-Deoxy-2-Amino Glucitol-6-Phosphate
  • N-acetyl-D-glucosamine-6-phosphate
KLK7 kallikrein related peptidase 7
  • Degradation of the extracellular matrix
  • L-alanyl-N-[(1S,2R)-1-benzyl-2-hydroxypropyl]-L-alaninamide
LATS2 large tumor suppressor kinase 2
  • Signaling by Hippo
LYPD3 LY6/PLAUR domain containing 3
  • Post-translational modification: synthesis of GPI-anchored proteins
MAP2K5 mitogen-activated protein kinase kinase 5
  • Signalling to ERK5
  • Fostamatinib
MARK4 microtubule affinity regulating kinase 4
  • Anchoring of the basal body to the plasma membrane
  • Fostamatinib
NANS N-acetylneuraminate synthase
  • Sialic acid metabolism

Page 5 out of 7 pages